Company intelligence / Profile preview
Smotect
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Smotect is a healthcare company dedicated to providing science-backed solutions for smoking cessation. The company offers a holistic approach to quitting smoking by combining pharmacological aids, such as nicotine replacement therapy and natural herbal tablets, with psychological support through a guided coaching program. Their flagship product, Smotect Natural Tablets, is a patented Ayurvedic formulation designed to reduce the urge to smoke and manage withdrawal symptoms. Smotect aims to improve respiratory health and overall well-being by helping individuals overcome nicotine addiction through a structured, evidence-based methodology. The company's solutions are clinically validated and focus on both the biological and psychological aspects of addiction.
- Therapeutic areas
- Psychiatry
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Smotect.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smotect.